PCCTC Trial Results: Neoadjuvant Enzalutamide Prior to Prostatectomy

May 9, 2017 | Press Releases

Study led by the University of Washington published in Clinical Cancer Research provides evidence of continued androgen receptor (AR) activity in residual tumor suggesting AR signaling may contribute to survival.

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.